Literature DB >> 3124181

Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine.

J J Hagan1, J H Jansen, C L Broekkamp.   

Abstract

Two experiments were conducted to determine the effects of the M1 muscarinic receptor antagonist pirenzepine on place navigation in a water maze. In the first experiment rats were required to learn the location of a hidden platform following intracerebroventricular injections of equimolar doses of pirenzepine or scopolamine methylbromide. Both drugs dose-dependently impaired spatial learning according to both escape latency data and transfer test analysis. Pirenzepine was approximately 3 times less potent than scopolamine, a potency ratio which suggests M1 receptor mediation of the impairment. In the second experiment pirenzepine (1 approximately 92.3 micrograms/rat ICV) was injected prior to training on a simultaneous place discrimination task in the water maze. Impairments of choice accuracy were found with a dose of 20 micrograms/rat in the absence of any marked increases in either errors of omission or choice latency. These data suggest that M1 receptor blockade impairs processes which are involved in spatial learning.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124181     DOI: 10.1007/bf00207237

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

1.  Allocentric spatial learning by hippocampectomised rats: a further test of the "spatial mapping" and "working memory" theories of hippocampal function.

Authors:  R G Morris; J J Hagan; J N Rawlins
Journal:  Q J Exp Psychol B       Date:  1986-11

2.  Cholinergic receptor interactions and their effects on long-term memory processing.

Authors:  J F Flood; D W Landry; M E Jarvik
Journal:  Brain Res       Date:  1981-06-29       Impact factor: 3.252

3.  Studies on muscarinic binding sites in human brain identified with [3H]pirenzepine.

Authors:  S C Lin; K C Olson; H Okazaki; E Richelson
Journal:  J Neurochem       Date:  1986-01       Impact factor: 5.372

4.  Acetylcholine hyperpolarizes central neurones by acting on an M2 muscarinic receptor.

Authors:  T M Egan; R A North
Journal:  Nature       Date:  1986 Jan 30-Feb 5       Impact factor: 49.962

5.  Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.

Authors:  R Cortés; J M Palacios
Journal:  Brain Res       Date:  1986-01-08       Impact factor: 3.252

6.  Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]-QNB and [3H]-pirenzepine.

Authors:  J K Wamsley; D R Gehlert; W R Roeske; H I Yamamura
Journal:  Life Sci       Date:  1984-04-02       Impact factor: 5.037

7.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

8.  Scopolamine degrades spatial working memory but spares spatial reference memory: dissimilarity of anticholinergic effect and restriction of distal visual cues.

Authors:  W W Beatty; R A Bierley
Journal:  Pharmacol Biochem Behav       Date:  1985-07       Impact factor: 3.533

9.  Disruption of central cholinergic systems in the rat by basal forebrain lesions or atropine: effects on feeding, sensorimotor behaviour, locomotor activity and spatial navigation.

Authors:  I Q Whishaw; W T O'Connor; S B Dunnett
Journal:  Behav Brain Res       Date:  1985 Sep-Oct       Impact factor: 3.332

10.  Muscarinic M1 and M2 receptors mediate depolarization and presynaptic inhibition in guinea-pig enteric nervous system.

Authors:  R A North; B E Slack; A Surprenant
Journal:  J Physiol       Date:  1985-11       Impact factor: 5.182

View more
  23 in total

1.  The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons.

Authors:  C Weiss; A R Preston; M M Oh; R D Schwarz; D Welty; J F Disterhoft
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

2.  Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory.

Authors:  R V Fornari; K M Moreira; M G Oliveira
Journal:  Learn Mem       Date:  2000 Sep-Oct       Impact factor: 2.460

3.  Network activity in neurons of the motor and prefrontal areas of the cortex in trained cats in conditions of systemic administration of m-cholinoreceptor blockers.

Authors:  V N Khokhlova; G Kh Merzhanova; E E Dolbakyan
Journal:  Neurosci Behav Physiol       Date:  2002 Nov-Dec

4.  The utility of muscarinic agonists in the treatment of Alzheimer's disease.

Authors:  William S Messer
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

5.  Carbachol-induced long-term synaptic depression is enhanced during senescence at hippocampal CA3-CA1 synapses.

Authors:  Ashok Kumar
Journal:  J Neurophysiol       Date:  2010-05-26       Impact factor: 2.714

6.  Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor.

Authors:  T Miyakawa; M Yamada; A Duttaroy; J Wess
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

7.  A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.

Authors:  Douglas J Sheffler; Richard Williams; Thomas M Bridges; Zixiu Xiang; Alexander S Kane; Nellie E Byun; Satyawan Jadhav; Mathew M Mock; Fang Zheng; L Michelle Lewis; Carrie K Jones; Colleen M Niswender; Charles D Weaver; Craig W Lindsley; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2009-04-30       Impact factor: 4.436

Review 8.  Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease.

Authors:  A I Levey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

9.  Effects of disrupting the cholinergic system on short-term spatial memory in rats.

Authors:  J S Andrews; J H Jansen; S Linders; A Princen
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

10.  Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1.

Authors:  C J Langmead; N E Austin; C L Branch; J T Brown; K A Buchanan; C H Davies; I T Forbes; V A H Fry; J J Hagan; H J Herdon; G A Jones; R Jeggo; J N C Kew; A Mazzali; R Melarange; N Patel; J Pardoe; A D Randall; C Roberts; A Roopun; K R Starr; A Teriakidis; M D Wood; M Whittington; Z Wu; J Watson
Journal:  Br J Pharmacol       Date:  2008-05-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.